Abstract:Magnetic Resonance Imaging(MRI)is a powerful method for clinical diagnosis and therapy due to the distinguishing characteristics of providing high-quality three-dimensional images of soft tissue without the need for harmful ionizing radiation.Complexes of gadolinium(Ⅲ)have proven to be especially effective M RI contrast agents,as it is estimated that they are needed for over 30% of the patients to accelerate relaxation rate of in vivo water protons,thus enhancing the contrast of different biological tissues and definition between normal tissues and diseased parts.For more sensitive small-molecule gadolinium-based M RI contrast agents,one essential requirement is to increase the hydration number q, which enhances the gadolinium's relaxivity.However,with the concern of chronic kidney disease(CKD) and nephrogenic systemic fibrosis(NSF),competition between strong chelate stability and free water coordination sites has increasingly become a challenge to M RI enhancement agent design.A highly stable N-oxide-DTPA-bisamide-based Gd(Ⅲ)complex with 3 coordinated water molecules is synthesized.The general methods such as 1 H-NMR,13C-NMR and ESI-MS spectroscopy are used to characterize the structures of the ligand and the complex.T he hydration number determined by the fluorescence lifetime of its Europium(Ⅲ)analogue is 3.M RI measurement show s much higher relaxivity value(16.39 mM -1·s-1) than commercial contrast agents.By fitting the potentiometric data with HYPERQUAD program,the formation constants of the Gd(Ⅲ)complex are calculated and demonstrated a superior stability over Gd-DTPA-BMA(Omniscan?).Meanwhile,in vivo imaging shows good imaging quality and cell tests reveal low cytotoxicity of the complexes,which indicate its great potential for future clinical applications.

Macromolecular MRI Contrast Agents: Structures, Properties and Applications

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Research Progress of Magnetic Resonance Imaging Contrast Agents

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Progress in MRI Contrast Agent Ligands Modified by Macromolecules

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application

Aptamer-Targeted Magnetic Resonance Imaging Contrast Agents and Their Applications

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

THE RESEARCH PROGRESS OF GADOLINIUM(Ⅲ)-BASED MACROMOLECULAR MRI CONTRAST AGENTS

Recent Advances on Stimuli-Responsive Macromolecular Magnetic Resonance Imaging (MRI) Contrast Agents

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

Development of Magnetic Resonance Imaging Contrast Agents with PAMAM Dendrimer Cores

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Gadolinium Complexes of Macrocyclic Diethylenetriamine-N-oxide Pentaacetic Acid-Bisamide As Highly Stable MRI Contrast Agents with High Relaxivity.

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents